Interact to see
Advertisement
Advertisement
HMDYX vs VMGMX
HMDYX vs VMGMX Comparison
Open Charts HMDYX vs VMGMX
Vanguard Mid-Cap Growth Index Admiral
Price$120.44
Change-$3.02 (-2.45%)
VolumeN/A
Net Assets33.11B
HMDYX vs VMGMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
HMDYX vs. VMGMX commentary
Nov 14, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMDYX is a Hold and VMGMX is a Hold.
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.1B vs. HMDYX (4.21B). VMGMX pays higher dividends than HMDYX: VMGMX (0.62) vs HMDYX (0.00). HMDYX was incepted earlier than VMGMX: HMDYX (28 years) vs VMGMX (14 years). HMDYX (0.86) is less costly to investors than VMGMX (0.07). HMDYX is a more actively managed with annual turnover of: 51.00 vs. VMGMX (21.00). VMGMX has a lower initial minimum investment than HMDYX: VMGMX (3000) vs HMDYX (250000). VMGMX annual gain was more profitable for investors over the last year : 9.00 vs. HMDYX (-9.69). VMGMX return over 5 years is better than : 48.04 vs. HMDYX (-19.66).
| HMDYX | VMGMX | HMDYX / VMGMX | |
| Total Expense Ratio | 0.86 | 0.07 | 1,229% |
| Annual Report Gross Expense Ratio | 0.86 | 0.07 | 1,229% |
| Fund Existence | 28 years | 14 years | - |
| Gain YTD | -1.898 | 13.082 | -15% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 3000 | 8,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.21B | 33.1B | 13% |
| Annual Yield % from dividends | 0.00 | 0.62 | - |
| Returns for 1 year | -9.69 | 9.00 | -108% |
| Returns for 3 years | 1.73 | 51.02 | 3% |
| Returns for 5 years | -19.66 | 48.04 | -41% |
| Returns for 10 years | 13.40 | 193.71 | 7% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PRHSX | 90.91 | -0.46 | -0.50% |
| T. Rowe Price Health Sciences | |||
| EPSRX | 25.24 | -0.28 | -1.10% |
| NYLI Epoch Global Equity Yield Class R6 | |||
| IRPSX | 10.51 | -0.12 | -1.13% |
| VY® T. Rowe Price Equity Income S | |||
| PMPRX | 15.77 | -0.18 | -1.13% |
| Principal MidCap Value I R3 | |||
| LPFCX | 5.29 | -0.13 | -2.40% |
| ALPS Global Opportunity C | |||